ArticleCancers2023

Advantage of First-Line Therapeutic Drug Monitoring-Driven Use of Infliximab for Treating Acute Intestinal and Liver GVHD in Children: A Prospective, Single-Center Study.

Natalia Maximova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.